Cite
HARVARD Citation
Mahoney, K. et al. (2022). Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for immunotherapy of cancer. 10 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mahoney, K. et al. (2022). Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for immunotherapy of cancer. 10 (2), p. . [Online].